Novartis (NVS) Stock Statistics & Valuation Metrics

Novartis has a market cap or net worth of $298.05B. The enterprise value is $329.23B.

Novartis has 2,112,421,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 15.50%.

The current PE Ratio of Novartis is 21.7. Novartis’s PEG ratio is 0.85.

In the last 12 months, Novartis had revenue of 54.81B and earned 14.06B in profits. Earnings per share was 7.25.

In the last 12 months, operating cash flow was 19.13B and capital expenditures -3.49B, giving a free cash flow of 15.64B billion.

Novartis pays an annual dividend of $3.994, resulting in a dividend yield of 2.87%

Novartis upcoming earnings date is Apr 28, 2026, TBA (Confirmed).

Novartis as a current ratio of 1.12, with Debt / Equity ratio of 80.28%

In the past 12 months, Novartis has paid 2.40B in taxes.

Novartis EV to EBITDA ratio is 12.74, with an EV/FCF ratio of 16.56.

Novartis has $11.59B in cash and marketable securities with $37.11B in debt, giving a net cash position of -$25.52B billion.

Gross margin is 75.62%, with operating margin of 31.15%, and net profit margin of 25.64%.

The average price target for Novartis is $123.67, which is 11.43% higher than the current price. The consensus rating is Hold